Clinical Trials Browser

Phase 1/2 × Completed × Prostatic Neoplasms, Castration-Resistant × Clear all

NCT04381832 2025-07-22

Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

Phase 1/2 Completed

Prostatic Neoplasms, Castration-Resistant

NCT01171729 2010-08-11

Autologous Dendritic Cell Therapy for Hormone-Refractory Metastatic Prostate Cancer

Phase 1/2 Completed

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant